|1.||Bartolomé-Nebreda, J M: 1 article (10/2004)|
|2.||García-López, M T: 1 article (10/2004)|
|3.||Herranz, R: 1 article (10/2004)|
|4.||Del Río, J: 1 article (10/2004)|
|5.||Cenarruzabeitia, E: 1 article (10/2004)|
|6.||Latorre, M: 1 article (10/2004)|
|7.||González-Muñiz, R: 1 article (10/2004)|
10/01/2004 - "Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis."
10/01/2004 - "Consequently, the pyridopyrimidine derivative IQM-97,423 is a potent and highly selective CCK1 receptor antagonist with preventive effects in two experimental models of acute pancreatitis and a potential therapeutic interest."
10/01/2004 - "In common bile-pancreatic duct ligature-induced acute pancreatitis, IQM-97,423 partially prevented, like devazepide, the increase in plasma pancreatic enzyme activity and in pancreas weight. "
10/01/2004 - "The protective effect of IQM-97,423 and devazepide was tested in two models of acute pancreatitis in rats, induced by injection of cerulein or by combined bile and pancreatic duct obstruction. "